Cargando…
Common molecular markers between circulating tumor cells and blood exosomes in colorectal cancer: a systematic and analytical review
Nearly half of patients with colorectal cancer (CRC), the third leading cause of cancer deaths worldwide, are diagnosed in the late stages of the disease. Appropriate treatment is not applied in a timely manner and nearly 90% of the patients who experience metastasis ultimately die. Timely detection...
Autores principales: | Vafaei, Somayeh, Fattahi, Fahimeh, Ebrahimi, Marzieh, Janani, Leila, Shariftabrizi, Ahmad, Madjd, Zahra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6768129/ https://www.ncbi.nlm.nih.gov/pubmed/31576171 http://dx.doi.org/10.2147/CMAR.S219699 |
Ejemplares similares
-
Potential theranostics of circulating tumor cells and tumor-derived exosomes application in colorectal cancer
por: Vafaei, Somayeh, et al.
Publicado: (2020) -
Expressions of TWIST1 and CD105 markers in colorectal cancer patients and their association with metastatic potential and prognosis
por: Fattahi, Fahimeh, et al.
Publicado: (2021) -
Low expression of Talin1 is associated with advanced pathological features in colorectal cancer patients
por: Vafaei, Somayeh, et al.
Publicado: (2020) -
Circulating cancer stem cell markers in breast carcinomas: a systematic review protocol
por: Mansoori, Maryam, et al.
Publicado: (2017) -
Copy Number Variation of Circulating Tumor DNA (ctDNA) Detected Using NIPT in Neoadjuvant Chemotherapy-Treated Ovarian Cancer Patients
por: Sharbatoghli, Mina, et al.
Publicado: (2022)